Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stents

Journal of Interventional Cardiology

Volumn 26, Issue 1, 2013, Pages 49-57

  Batchelor, Wayne B ^a   Ellis, Stephen G ^b   Ormiston, John A ^c   Stone, Gregg W ^d   Joshi, Anita A ^e   Wang, Hong ^e   Underwood, Paul L ^e,f  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Mercy Hospital   (New Zealand)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^e BOSTON SCIENTIFIC CORPORATION   (United States)

^f Interventional Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ASIAN; BARE METAL STENT; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NEGRO; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SILENT MYOCARDIAL ISCHEMIA; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TREATMENT OUTCOME;

CARDIOTONIC AGENTS; CONTINENTAL POPULATION GROUPS; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOSIS;

EID: 84874042177     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00760.x     Document Type: Article

References (29)

1. Day JC,. Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050, U.S. Bureau of the Census, current population reports 1996; 25-1130.
2. Berger JS, Melloni C, Wang TY, et al. Reporting and representation of race/ethnicity in published randomized trials. Am Heart J 2009; 158: 742-747.
3. Mastoor M, Iqbal U, Pinnow E, et al. Ethnicity does not affect outcomes of coronary angioplasty. Clin Cardiol 2000; 23: 379-382. (Pubitemid 30241748)
4. Iqbal U, Pinnow EE, Lindsay J Jr., Comparison of six-month outcomes after percutaneous coronary intervention for Whites versus African-Americans. Am J Cardiol 2000; 88: 304-305.
5. Scott NA, Kelsey SF, Detre K, et al. Percutaneous transluminal angioplasty in African-American patients (the National Heart, Lung, and Blood Institute 1985-1886 Percutaneous Transluminal Angioplasty Registry). Am J Cardiol 1994; 73: 1141-1146. (Pubitemid 24184384)
6. Marks DS, Mensah GA, Kennard ED, et al. Race, baseline characteristics, and clinical outcomes after coronary intervention: The new approaches in coronary interventions (NACI) registry. Am Heart J 2000; 140: 162-169. (Pubitemid 30471258)
7. Slater J, Selzer F, Dorbala S, et al. Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2003; 92: 773-778. (Pubitemid 37163568)
8. Pradhan J, Schreiber TL, Niraj A, et al. Comparison of five-year outcome in African Americans versus Caucasians following percutaneous coronary intervention. Catheter Cardiovasc Interv 2008; 72: 36-44. (Pubitemid 352008979)
9. Chen MS, Bhatt DL, Chew DP, et al. Outcomes in African Americans and whites after percutaneous coronary intervention. Am J Med 2005; 118: 1019-1025. (Pubitemid 41297767)
10. Leborgne L, Cheneau E, Wolfram R, et al. Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention. Am J Cardiol 2004; 93: 389-393. (Pubitemid 38221342)
11. Minutello RM, Chou ET, Hong MK, et al. Impact of race and ethnicity on inhospital outcomes after percutaneous coronary intervention (report from the 2000-2001 New York State Angioplasty Registry). Am Heart J 2006; 151: 164-167. (Pubitemid 41815348)
12. Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST elevation acute coronary syndromes: Insights from CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines?). Circulation 2005; 111: 1225-1232. (Pubitemid 40389085)
13. Mehta RH, Marks D, Califf RM, et al. Differences in the clinical features and outcomes in African Americans and Whites with myocardial infarction. Am J Med 2006; 119: 2111-2116.
14. Berger JS, Sanborn TA, Sherman W, et al. Comparison of three-year outcomes in blacks versus whites with coronary heart disease following percutaneous coronary intervention. Am J Cardiol 2004; 94: 647-649. (Pubitemid 39165848)
15. Jacobi JA, Parikh SV, Mcguire DK, et al. Racial disparity in clinical outcomes following primary percutaneous coronary intervention for ST elevation myocardial infarction: Influence of process of care. J Interv Cardiol 2007; 20: 182-187. (Pubitemid 46808884)
16. Gaglia MA, Steinberg DH, Pinto Slottow TL, et al. Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol 2009; 103: 653-658.
17. Collins SD, Torguson R, Gaglia MA, et al. Does black ethnicity influence the development of stent thrombosis in the drug-eluting stent era? Circulation 2010; 122: 1085-1090.
18. Stone GW, Ellis SG, Cox DA, et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231. (Pubitemid 38067635)
19. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005; 294: 1215-1223. (Pubitemid 41352109)
20. Turco MA, Ormiston JA, Popma JJ, et al. Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: The pivotal TAXUS ATLAS trial. J Am Coll Cardiol 2007; 49: 1676-1683. (Pubitemid 46589927)
21. Turco MA, Ormiston JA, Popma JJ, et al. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin strut TAXUS Liberté stent: 1 year results from the TAXUS ATLAS Program. JACC Cardiovasc Interv 2008; 1: 1699-1709.
22. Mauri L, Hsieh W, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029. (Pubitemid 46376802)
23. Whittle J, Conigliaro J, Good CB, et al. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs. N Engl J Med 1993; 329: 621-627. (Pubitemid 23244815)
24. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, et al. Racial differences in the use of revascularization procedures after coronary angiography. JAMA 1993; 269: 2642-2646. (Pubitemid 23147700)
25. Peterson ED, Shaw LK, DeLong ER, et al. Racial variation in the use of coronary-revascularization procedures: Are the differences real? Do they matter? N Engl J Med 1997; 336: 480-486. (Pubitemid 27074360)
26. Chen J, Rathore SS, Radford MJ, et al. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med 2001; 344: 1443-1449. (Pubitemid 32402102)
27. Gaglia MA, Torguson R, Xue Z, et al. Insurance type influences the use of drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 773-779.
28. Leon MB, Allocco DJ, Dawkins KD, et al. Late clinical events after drug-eluting stents: The interplay between stent-related and natural history-driven events. JACC Cardiovasc Interv 2009; 2: 504-512.
29. Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trial. Lancet 2010; 375: 201-209.